| TEMPLETON EMERGING MARKETS A (ACC) USD | RVI EMERGENTES | 74,326081 | 16/09/2026 | 31,55% | 88,79% | ***** |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 64,110000 | 16/09/2026 | 17,78% | 88,78% | **** |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES I EUR | RVI EMERGENTES | 458,690000 | 16/09/2026 | 29,72% | 88,78% | ***** |
| TEMPLETON EMERGING MARKETS A (ACC) HKD | RVI EMERGENTES | 2,769951 | 16/09/2026 | 31,54% | 88,77% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 4,946579 | 16/09/2026 | 17,61% | 88,76% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 59,365520 | 16/09/2026 | 17,59% | 88,76% | ***** |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI A EUR ACC | RVI EMERGENTES | 27,480000 | 16/09/2026 | 30,73% | 88,74% | ***** |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES I USD | RVI EMERGENTES | 261,107740 | 16/09/2026 | 29,79% | 88,66% | ***** |
| BRIGHTGATE FOCUS, FI A | RVI GLOBAL | 2.573,944800 | 11/09/2026 | 20,70% | 88,62% | ***** |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 64,115455 | 16/09/2026 | 17,86% | 88,61% | **** |
